SurModics, Inc. (NASDAQ:SRDX)

squidfungus (< 20) Submitted: 10/5/2012 5:04:28 PM : Start Price: $20.90 SRDX Score: +10.94

This is a pharmaceutical company that company that has very limited competition. The manufacture a product that requires FDA approval to enter as a competitor.

gunterle (65.54) Submitted: 8/3/2012 11:53:26 AM : Start Price: $17.70 SRDX Score: +29.56

signal

phatchips767 (< 20) Submitted: 1/23/2012 6:18:17 PM : Start Price: $14.47 SRDX Score: +54.89

trackfeltland likeeed em.. Did well in two months.

EclecticRecluse (77.87) Submitted: 5/16/2011 7:36:54 AM : Start Price: $15.12 SRDX Score: +49.68

Earnings Estimates Revised Upward

jsgant13 (99.10) Submitted: 11/30/2010 10:36:24 AM : Start Price: $9.23 SRDX Score: +145.30

oozing alpha activist play

paggles (73.66) Submitted: 2/14/2009 2:25:27 AM : Start Price: $18.99 SRDX Score: -72.88

Well positioned for growth in healthcare sector. Could be bought by major drug company by the end of 2009. Several things to like for the beaten down price

rklapman (88.95) Submitted: 12/15/2008 8:41:00 PM : Start Price: $23.32 SRDX Score: -80.71

Expect takeover by JNJ

harrytong (91.79) Submitted: 10/17/2008 3:36:22 AM : Start Price: $25.60 SRDX Score: +83.03

expensive.

HoldSideAnalyst (< 20) Submitted: 7/30/2007 5:23:31 PM : Start Price: $47.60 SRDX Score: -62.99

Stent worries overdone. Regardless, this company has real opportunities beyond the stent market.

aaroger (86.28) Submitted: 7/20/2007 5:20:51 AM : Start Price: $46.98 SRDX Score: +57.24

53

cccruz (35.65) Submitted: 7/6/2007 9:38:51 PM : Start Price: $52.37 SRDX Score: -64.31

Still has 5 potential opthamology deals to be signed in addition to Merck. Diverse portfolio of customes and products. Great patent coverage. No debt. Recent stock buyback. High short interest due to investors who feel Surmodics is a one trick pony with stents.

skc0001 (< 20) Submitted: 6/18/2007 3:10:08 AM : Start Price: $37.90 SRDX Score: -44.89

Proposed by Good People

marionvb (54.08) Submitted: 2/2/2007 9:05:58 PM : Start Price: $36.94 SRDX Score: -50.96

new antibiotic beads, JNJ business recovering, no debt

mrnew (59.42) Submitted: 1/19/2007 2:50:10 PM : Start Price: $31.13 SRDX Score: -39.17

Value of the pipeline is being overwhelmed by the debate on the value of coated stents.

morgnlll (< 20) Submitted: 12/9/2006 9:19:04 PM : Start Price: $33.13 SRDX Score: -45.57

Will win out in the coated stent race.

jddixon1 (< 20) Submitted: 10/10/2006 1:46:09 PM : Start Price: $34.19 SRDX Score: -54.10

Market for their coatings will increase as boomers age and we all get .... larger.